Neurotune's Diagnostic Boosts Odds for Sarcopenia Program
By Nuala Moran
Wednesday, March 7, 2012
LONDON Neurotune AG launched the first validated blood test for sarcopenia, a move it said has made its putative treatments for the muscle-wasting disease more attractive to potential pharma partners.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.